Accord UK sponsoring C+D’s ‘Above and Beyond’ Award tomorrow!

Accord UK will be attending the C+D Awards evening tomorrow night. These awards recognise best practice and reward excellence in community pharmacy.

Read more


Accord-UK exhibit at the British Society for Rheumatology Conference 2019

Accord-UK were pleased to exhibit at the British Society for Rheumatology Conference this week.

Read more


Celebrating ‘National Apprenticeship Week 2019’

Read more


International suppliers meet at Accord Fawdon to celebrate growing together in partnership

Accord Fawdon recently hosted a special event to celebrate its supplier partnerships. 

Read more


Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare

Taipei, Taiwan and Harrow, England, February 11, 2019 – An exclusive license agreement for the commercialisation of Foresee Pharmaceutical’s (6576.TWO) novel FP-001 program (leuprorelin depot...

Read more


The Falsified Medicines Directive – Sandra Lee’s interview published in Pharmacy Business – February 2019 edition

Sandra Lee, Managing Director of Operations, explains why FMD is important and how the industry is preparing.

Read more


Accord Fawdon celebrates its one year anniversary

The team at Accord Fawdon recently celebrated the factory’s one-year anniversary with cakes and reflections on the successes of the past year.

Read more


Accord and other leading voices in the pharmaceutical and financial industry debate how to drive consistent and long-term growth

In November 2018, at the House of Lords, Accord partnered Generics bulletin to bring influential industry experts together at an intimate roundtable to talk about how pharma companies should...

Read more


Accord UK leading the conversation on how biosimilars can improve access to effective cancer treatments

Cancer is one of the biggest global healthcare challenges facing clinicians today. The rising cost of treatments can affect patients’ access to affordable, effective treatments.


Read more